Antoris MR 35 mg is a modified-release tablet containing Trimetazidine Dihydrochloride, manufactured by Opsonin Pharma Ltd. in Bangladesh. It is used as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.